Publication: Prescriber compliance to direct oral anticoagulant labels and impact on outcomes in Thailand
0
0
Issued Date
2020
Resource Type
File Type
application/pdf
ISSN
3065251
Other identifier(s)
2-s2.0-85090448785
Rights Holder(s)
มหาวิทยาลัยศรีนครินทรวิโรฒ
Bibliographic Citation
British Journal of Clinical Pharmacology. (2020)
Suggested Citation
Wattanaruengchai P., Nathisuwan S., Rattanavipanon W., Chulavatnatol S., Kongwatcharapong J., Mitsuntisuk P., Chaiyasothi T., Kritsanapipat D., Phrommintikul A., Chaiyakunapruk N., Likittanasombat K., Lip G.Y.H. Prescriber compliance to direct oral anticoagulant labels and impact on outcomes in Thailand. British Journal of Clinical Pharmacology. (2020). doi:10.1111/bcp.14535 Retrieved from: https://hdl.handle.net/20.500.14740/4985
Abstract
Aims: This study aimed to evaluate the prescriber compliance to the approved labels of direct oral anticoagulants (DOACs) and impact of appropriateness of dosing on clinical outcomes. Methods: A retrospective study was conducted using simple-stratified random sampling of adult patients receiving ≥6 months of DOACs for various indications during 2013–2017 in 10 tertiary care hospitals. Patients were classified into 3 dosing groups including approved dose, underdosing and overdosing based on the Thai Food and Drug Administration-approved labels. Cox proportional hazard models were used to evaluate the impact of different dosings on thromboembolic and bleeding events. Results: From 1200 patients included in the data analysis, prescribing of DOACs was consistent with the approved indications in 1130 cases (94.2%) while 70 patients (5.8%) received DOACs despite having contraindications or with off-label usage. Among 1026 cases of dosing evaluation cohort, 688 patients (67.1%) received approved doses. There were 227 (21.9%) and 110 (10.7%) cases of underdosing and overdosing, respectively. Multivariate analysis showed that underdosing was associated with an increased risk of thromboembolism 3.023 (95% confidence interval [CI]: 1.291–7.080; P =.011) while overdosing was associated with an increased risk of bleeding requiring hospitalization (adjusted hazard ratio, 3.045; 95% CI, 1.501–6.178; P =.002) and Bleeding Academic Research Consortium type 2 or more (adjusted hazard ratio, 2.196; 95% CI, 1.083–4.452; P =.029). Conclusion: Prescribers’ compliance to approved indications were high. However, 1/3 of DOAC prescriptions were inconsistent with approved dosing. Dosing deviation was associated with an increase in adverse clinical outcomes. © 2020 The British Pharmacological Society